N-Fmoc-3,5-difluoro-L-phenylalanine is a non-natural, fluorinated amino acid derivative. Its structure features an L-phenylalanine backbone with fluorine atoms substituted at the 3 and 5 positions of the aromatic ring, and the alpha-amino group is protected by a 9-fluorenylmethoxycarbonyl (Fmoc) group. This compound is a crucial building block in solid-phase peptide synthesis (SPPS) using the Fmoc strategy. The fluorine substitutions on the phenyl ring significantly alter the electronic properties, lipophilicity, and metabolic stability of the resulting peptide. It is primarily used to incorporate fluorinated aromatic residues into synthetic peptides and peptidomimetics for pharmaceutical research, enabling the study of structure-activity relationships, enhancing peptide stability against enzymatic degradation, and modulating receptor binding affinity. As a specialty amino acid derivative, it is a key reagent in medicinal chemistry for developing peptide-based therapeutics, probes, and diagnostic agents. Its use requires standard handling procedures for peptide synthesis reagents.